Gujarat Themis Biosyn LtdPharmaceuticalsINE942C01045Consolidated₹414.40-13.25 (-3.10%)Jun-26
Valuation
Market Cap₹4.52K Cr
TTM PE406.27x
Forward PE-29.10x
PEG644.87
Book Value₹26.41
P/B15.69x
TTM EPS₹1.02
Fwd EPS₹-14.24
TTM Revenue₹165.82 Cr
TTM PAT₹46.68 Cr
TTM EBITDA₹75.53 Cr
TTM EBIT₹62.61 Cr
Last Qtr PAT₹11.07 Cr
Last Qtr EBITDA₹75.53 Cr
Last Qtr EBIT₹62.61 Cr
Profitability
ROE16.22%
ROCE4.52%
TTM NPM28.15%
TTM EBITDA %45.55%
Curr OPM25.20%
Last OPM-8.41%
Curr NPM—
Last NPM—
Curr EPS₹1.02
Last EPS₹-4.82
Balance sheet
Equity₹10.90 Cr
Reserve₹276.86 Cr
Total Debt₹161.81 Cr
D/E0.56x
Interest %16.17%
Curr Interest₹1.79 Cr
Price / range
Close₹414.40
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-3.10%
1W-2.11%
1M+8.79%
3M+8.16%
6M+50.64%
1Y+7.45%
2Y+13.22%
3Y+261.38%
5Y+402.12%
Diwali-5.81%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 2 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits